1. Home
  2. APPN vs AVDL Comparison

APPN vs AVDL Comparison

Compare APPN & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APPN
  • AVDL
  • Stock Information
  • Founded
  • APPN 1999
  • AVDL 2015
  • Country
  • APPN United States
  • AVDL Ireland
  • Employees
  • APPN N/A
  • AVDL N/A
  • Industry
  • APPN Computer Software: Prepackaged Software
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • APPN Technology
  • AVDL Health Care
  • Exchange
  • APPN Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • APPN 2.0B
  • AVDL 1.8B
  • IPO Year
  • APPN 2017
  • AVDL 1996
  • Fundamental
  • Price
  • APPN $40.15
  • AVDL $18.70
  • Analyst Decision
  • APPN Hold
  • AVDL Buy
  • Analyst Count
  • APPN 6
  • AVDL 9
  • Target Price
  • APPN $35.20
  • AVDL $18.06
  • AVG Volume (30 Days)
  • APPN 867.6K
  • AVDL 4.8M
  • Earning Date
  • APPN 11-06-2025
  • AVDL 11-04-2025
  • Dividend Yield
  • APPN N/A
  • AVDL N/A
  • EPS Growth
  • APPN N/A
  • AVDL N/A
  • EPS
  • APPN N/A
  • AVDL N/A
  • Revenue
  • APPN $690,755,000.00
  • AVDL $248,517,000.00
  • Revenue This Year
  • APPN $15.42
  • AVDL $64.21
  • Revenue Next Year
  • APPN $11.07
  • AVDL $30.80
  • P/E Ratio
  • APPN N/A
  • AVDL N/A
  • Revenue Growth
  • APPN 15.96
  • AVDL 79.88
  • 52 Week Low
  • APPN $24.00
  • AVDL $6.38
  • 52 Week High
  • APPN $43.33
  • AVDL $19.06
  • Technical
  • Relative Strength Index (RSI)
  • APPN 78.76
  • AVDL 73.80
  • Support Level
  • APPN $28.56
  • AVDL $18.74
  • Resistance Level
  • APPN $30.63
  • AVDL $19.00
  • Average True Range (ATR)
  • APPN 1.54
  • AVDL 0.35
  • MACD
  • APPN 0.97
  • AVDL 0.00
  • Stochastic Oscillator
  • APPN 95.47
  • AVDL 89.36

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: